Enrollment factors and bias of disease prevalence estimates in administrative claims data.
Enrollment factors and bias of disease prevalence estimates in administrative claims data.
复制标题
DOI:
10.1016/j.annepidem.2015.03.008
复制
发表时间:
2015-07
影响因子:
5.6
通讯作者:
Dellon ES
中科院分区:
文献类型:
--
作者:
Jensen ET;Cook SF;Allen JK;Logie J;Brookhart MA;Kappelman MD;Dellon ES
Considerations for using administrative claims data in research have not been well-described. To increase awareness of how enrollment factors and insurance benefit use may contribute to observed estimates, we evaluated how differences in operational definitions of the cohort impacted estimates of disease prevalence. We conducted a cross-sectional study estimating the prevalence of five gastrointestinal conditions using MarketScan claims data for 73.1 million enrollees. We extracted data obtained from 2009–2012 to identify cohorts meeting various enrollment, prescription drug benefit, or healthcare utilization characteristics. Next, we identified patients meeting the case definition for each of the diseases of interest. We compared the estimates obtained to evaluate the influence of enrollment period, drug benefit, and insurance usage. As the criteria for inclusion in the cohort became increasingly restrictive the estimated prevalence increased, as much as 45% to 77% depending on the disease condition and the definition for inclusion in the cohort. Requiring use of the benefit and a longer period of enrollment had the greatest influence on the estimates observed. Individuals meeting case definition were more likely to meet the more stringent definition for inclusion in the study cohort. This may be considered a form of selection bias, where overly restrictive cohort definitions may result in selection of a study population that may no longer represent the source population.